Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer
Clinical trial NCT01602406 · COMPLETED
Trial details
- NCT number
- NCT01602406
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-21
- Primary completion
- 2017-08-02
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.